Not applicableNot Yet RecruitingNCT06720480What this trial is testingThalassaemia SeverityWho this might be right forThalassaemia Assiut University 85
Testing effectiveness (Phase 2)Study completedNCT01303380What this trial is testingCanakinumab in Patients With Active Hyper-IgD SyndromeWho this might be right forMevalonate Kinase Deficiency Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT00968162What this trial is testingSickle Cell Disease Conditioning for Bone Marrow TransplantWho this might be right forBone Marrow TransplantationSickle Cell Disease Emory University 8
Testing effectiveness (Phase 2)UnknownNCT02737462What this trial is testingPhase 1/2 Study of CG200745 PPA for Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome CrystalGenomics, Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT01403246What this trial is testingChlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 9
Large-scale testing (Phase 3)Active Not RecruitingNCT04181827What this trial is testingA Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 419
Large-scale testing (Phase 3)Study completedNCT01486927What this trial is testingAn Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia AWho this might be right forHemophilia A CSL Behring 175
Testing effectiveness (Phase 2)Study completedNCT01001442What this trial is testingSafety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Biotest Pharmaceuticals Corporation 35
Not applicableUnknownNCT04447937What this trial is testingImmunodeficiency in MSWho this might be right forMultiple SclerosisHypogammaglobulinemiaImmunodeficiency+1 more Advanced Neurosciences Institute 1,500
Testing effectiveness (Phase 2)Study completedNCT01218477What this trial is testingDasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)Who this might be right forLeukemia Bristol-Myers Squibb 33
Testing effectiveness (Phase 2)Study completedNCT01202877What this trial is testingPKC412 and 5-AzacytidineWho this might be right forLeukemia M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT01627275What this trial is testingNaive T-Cell Depleted DLI Following Allo Stem Cell TransplantWho this might be right forHematological Malignancies Mitchell Horwitz, MD 28
Testing effectiveness (Phase 2)Study completedNCT00565981What this trial is testingA Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseWho this might be right forB-cell Chronic Lymphocytic Leukemia Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Testing effectiveness (Phase 2)UnknownNCT01883219What this trial is testingTKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaWho this might be right forPhiladelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease Nanfang Hospital, Southern Medical University 80
Not applicableStudy completedNCT02825667What this trial is testingEffectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of AnkleWho this might be right forHaemophilia Real Fundación Victoria Eugenia 65
Testing effectiveness (Phase 2)Looking for participantsNCT06503107What this trial is testingNanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMMWho this might be right forMultiple Myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT01016600What this trial is testingAzacitidine and Lenalidomide for Acute Myeloid LeukemiaWho this might be right forLeukemia, Myeloid, Acute Washington University School of Medicine 31
Not applicableUnknownNCT05181436What this trial is testingThe Prevalence of Malaysian Children Aged ≥ 6 to ≤ 36 Months at Risk of AnaemiaWho this might be right forAnemia Danone Specialized Nutrition (M) Sdn Bhd 1,215
Early research (Phase 1)Study completedNCT02316964What this trial is testingDecitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more Sumithira Vasu 8
Not applicableStudy completedNCT00721864What this trial is testingThe Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)Who this might be right forHemoglobinuria, Paroxysmal University of Utah 10